IP Library Granted Patent US 12673205
Granted Patent B2
US 12673205 · App. 18/373,673 · Granted Jul 7, 2026

Treatment of inflammation by selective DMV cholinergic neuron stimulation

Inventors: Adam M. Kressel (Plainview, NY); Valentin A. Pavlov (Bayside, NY); Sangeeta S. Chavan (Syosset, NY); Kevin J. Tracey (Old Greenwich, CT)
Assignee: The Feinstein Institutes for Medical Research
A61N1/36053A61N1/0412A61N1/0536A61N1/3615A61N1/0504
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12673205
App. No.
18/373,673
Granted
Jul 7, 2026
Kind
B2
Abstract

Methods for electrical modulation of inflammation or serum TNF levels in a subject.

Claims (6)

1 . A method of artificially increasing splenic norepinephrine release in a subject comprising selectively artificially electrically stimulating cholinergic neurons in a dorsal motor nucleus of a vagal nerve of the subject, wherein no other source of vagal nerve activity is artificially electrically stimulated, effective to increase splenic norepinephrine release.

2 . The method of claim 1 , wherein the subject is human.

3 . The method of claim 1 , wherein the subject has sepsis or is developing sepsis.

4 . The method of claim 1 , wherein the subject has endotoxemia, septicemia or septic shock.

5 . The method of claim 1 , wherein electrically stimulating is effected using microelectrodes placed in the subject's central nervous system.

6 . The method of claim 5 , wherein the microelectrodes are positioned stereotactically prior to electrical stimulation.